sigma-1 and sigma-2 ligands (Anavex Life Science/Oncodesign/University of Athens)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesigma-1 and sigma-2 ligands (Anavex Life Science/Oncodesign/University of Athens)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma-2 receptor modulators
TargetsSigma-2 receptor
Therapy Area/IndicationsNeuralgiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceGreece
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of AthensOncodesign ServicesAnavex Life Sciences Corp
Active IndicationsN/A
Inactive IndicationsNeuralgiaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A